Copyright Reports & Markets. All rights reserved.

Global Brand Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Brand Drugs Market Overview

      • 1.1 Product Overview and Scope of Brand Drugs
      • 1.2 Brand Drugs Segment by Type
        • 1.2.1 Global Brand Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Biopharmaceutical
        • 1.2.3 Chemistry Medicine
      • 1.3 Brand Drugs Segment by Application
        • 1.3.1 Brand Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Other
      • 1.4 Global Brand Drugs Market by Region
        • 1.4.1 Global Brand Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Brand Drugs Market Size
        • 1.5.1 Global Brand Drugs Revenue (2014-2025)
        • 1.5.2 Global Brand Drugs Production (2014-2025)

      2 Global Brand Drugs Market Competition by Manufacturers

      • 2.1 Global Brand Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Brand Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Brand Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Brand Drugs Production Sites, Area Served, Product Types
      • 2.5 Brand Drugs Market Competitive Situation and Trends
        • 2.5.1 Brand Drugs Market Concentration Rate
        • 2.5.2 Brand Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Brand Drugs Production Market Share by Regions

      • 3.1 Global Brand Drugs Production Market Share by Regions
      • 3.2 Global Brand Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Brand Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Brand Drugs Production
        • 3.4.1 North America Brand Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Brand Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Brand Drugs Production
        • 3.5.1 Europe Brand Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Brand Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Brand Drugs Production (2014-2019)
        • 3.6.1 China Brand Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Brand Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Brand Drugs Production (2014-2019)
        • 3.7.1 Japan Brand Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Brand Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Brand Drugs Consumption by Regions

      • 4.1 Global Brand Drugs Consumption by Regions
      • 4.2 North America Brand Drugs Consumption (2014-2019)
      • 4.3 Europe Brand Drugs Consumption (2014-2019)
      • 4.4 China Brand Drugs Consumption (2014-2019)
      • 4.5 Japan Brand Drugs Consumption (2014-2019)

      5 Global Brand Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Brand Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Brand Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Brand Drugs Price by Type (2014-2019)
      • 5.4 Global Brand Drugs Production Growth by Type (2014-2019)

      6 Global Brand Drugs Market Analysis by Applications

      • 6.1 Global Brand Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Brand Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Brand Drugs Business

      • 7.1 Pfizer
        • 7.1.1 Pfizer Brand Drugs Production Sites and Area Served
        • 7.1.2 Brand Drugs Product Introduction, Application and Specification
        • 7.1.3 Pfizer Brand Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Roche
        • 7.2.1 Roche Brand Drugs Production Sites and Area Served
        • 7.2.2 Brand Drugs Product Introduction, Application and Specification
        • 7.2.3 Roche Brand Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Sanofi
        • 7.3.1 Sanofi Brand Drugs Production Sites and Area Served
        • 7.3.2 Brand Drugs Product Introduction, Application and Specification
        • 7.3.3 Sanofi Brand Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Johnson & Johnson
        • 7.4.1 Johnson & Johnson Brand Drugs Production Sites and Area Served
        • 7.4.2 Brand Drugs Product Introduction, Application and Specification
        • 7.4.3 Johnson & Johnson Brand Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Merck & Co. (MSD)
        • 7.5.1 Merck & Co. (MSD) Brand Drugs Production Sites and Area Served
        • 7.5.2 Brand Drugs Product Introduction, Application and Specification
        • 7.5.3 Merck & Co. (MSD) Brand Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Novartis
        • 7.6.1 Novartis Brand Drugs Production Sites and Area Served
        • 7.6.2 Brand Drugs Product Introduction, Application and Specification
        • 7.6.3 Novartis Brand Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 AbbVie
        • 7.7.1 AbbVie Brand Drugs Production Sites and Area Served
        • 7.7.2 Brand Drugs Product Introduction, Application and Specification
        • 7.7.3 AbbVie Brand Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Gilead Sciences
        • 7.8.1 Gilead Sciences Brand Drugs Production Sites and Area Served
        • 7.8.2 Brand Drugs Product Introduction, Application and Specification
        • 7.8.3 Gilead Sciences Brand Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 GlaxoSmithKline (GSK)
        • 7.9.1 GlaxoSmithKline (GSK) Brand Drugs Production Sites and Area Served
        • 7.9.2 Brand Drugs Product Introduction, Application and Specification
        • 7.9.3 GlaxoSmithKline (GSK) Brand Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Amgen
        • 7.10.1 Amgen Brand Drugs Production Sites and Area Served
        • 7.10.2 Brand Drugs Product Introduction, Application and Specification
        • 7.10.3 Amgen Brand Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 AstraZeneca
      • 7.12 Bristol-Myers Squibb
      • 7.13 Eli Lilly
      • 7.14 Teva
      • 7.15 Bayer
      • 7.16 Novo Nordisk
      • 7.17 Allergan
      • 7.18 Shire
      • 7.19 Boehringer Ingelheim
      • 7.20 Takeda

      8 Brand Drugs Manufacturing Cost Analysis

      • 8.1 Brand Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Brand Drugs
      • 8.4 Brand Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Brand Drugs Distributors List
      • 9.3 Brand Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Brand Drugs Market Forecast

      • 11.1 Global Brand Drugs Production, Revenue Forecast
        • 11.1.1 Global Brand Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Brand Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Brand Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Brand Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Brand Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Brand Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Brand Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Brand Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Brand Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Brand Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Brand Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Brand Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Brand Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Brand Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Brand Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.

        The global Brand Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Brand Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Brand Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Pfizer
        Roche
        Sanofi
        Johnson & Johnson
        Merck & Co. (MSD)
        Novartis
        AbbVie
        Gilead Sciences
        GlaxoSmithKline (GSK)
        Amgen
        AstraZeneca
        Bristol-Myers Squibb
        Eli Lilly
        Teva
        Bayer
        Novo Nordisk
        Allergan
        Shire
        Boehringer Ingelheim
        Takeda

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Biopharmaceutical
        Chemistry Medicine

        Segment by Application
        Hospital
        Clinic
        Other

        Buy now